HOME >> BIOLOGY >> NEWS
First target for childhood malaria vaccine

The discovery of a malaria parasite protein that is associated with the severe childhood form of the disease could save the lives of many thousands of children in sub-Saharan Africa. Anja Jensen and colleagues, reporting in The Journal of Experimental Medicine, suggest that this protein could form the basis of a new vaccine against severe malaria.

The malaria-causing parasite Plasmodium falciparum, which is transmitted by mosquito bite, replicates in human red blood cells, which then burst causing life-threatening fever. Infected red blood cells display parasite proteins on their surface that help the parasite to survive in their human host and cause disease complications.

People who have grown up in regions where malaria is endemic usually develop protective antibodies to these parasite proteins, and symptoms in adults are mild compared with the severe disease seen in young children with no previous exposure. Previous work has indicated that the parasites causing severe disease express a set of proteins that are distinct from those produced by parasites that infect adults. But up to this point, no one had identified any of these proteins.

The authors developed a new method to compare for the first time the proteins that are expressed by two types of P. falciparum that cause severe childhood malaria and less severe adult infection, respectively. They identified one protein that is expressed on the surface of red blood cells during severe childhood malaria but not during adult infections. This protein causes infected red blood cells to stick inside blood vessels, preventing their removal in the spleen.

The study also found that this protein, unlike similar malaria proteins studied, does not vary between malaria parasites from East and West Africa, making it an ideal candidate for a universal vaccine to boost immunity to severe malaria in young children.


'"/>

Contact: Lynette Henry
henryn@rockefeller.edu
212-327-8575
Journal of Experimental Medicine
3-May-2004


Page: 1

Related biology news :

1. First glimpse of DNA binding to viral enzyme
2. First clinical study of new pediatric croup vaccine shows safety, tolerability in adults
3. 2nd media alert First Scientific Conference on Childhood Leukaemia
4. First International Scientific Conference on Childhood Leukaemia
5. First ever standards linking climate change, biodiversity and poverty seek global peer review
6. First genetic comparison of purebred domestic dogs produces surprises
7. First time in the U.S.: Saint Louis University tests third-generation vaccine against smallpox
8. First study of resveratrol dietary supplement finds effect on breast and prostate cancers unlikely
9. First flavors form a lasting impression
10. STN International launches Derwent World Patents Index First View
11. First DFG research conference in the USA

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/31/2019)... ... May 30, 2019 , ... Enso Discoveries Chief Executive Officer, Patrick Farley, is ... as a way to express his gratitude and respect for those who have served ... Enso Discoveries — presented a check for $1,000 to the Green Beret ...
(Date:5/24/2019)... (PRWEB) , ... May 24, 2019 , ... The newest ... and is now available on the company’s global website. , Crystallography Times is a ... crystal X-ray diffraction. It serves the X-ray analysis community by presenting the latest news ...
(Date:5/23/2019)... SAN FRANCISCO (PRWEB) , ... May 23, 2019 ... ... Intelligent Virtual Agents for sales and service organizations, today announced its ... report identifies Inference Solutions as the intelligent virtual agent (IVA) market share leader, ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ... June 10, 2019 , ... Advancements with Ted ... episode, scheduled to broadcast 4Q/2019. Check your local listings for more information. , ... about how its technology facilitates laboratories to improve efficiency and quality of research ...
(Date:6/11/2019)... (PRWEB) , ... June 11, 2019 , ... ... of Personalized Stem Cells Inc. (PSC) , has announced that their GMP ... Health, Food and Drug Branch for manufacturing. This is an important milestone ...
(Date:5/31/2019)... ... 2019 , ... For many years, the primary forms of cancer treatment have ... Advances in immuno-oncology have led to the advent of Chimeric Antigen Receptor T (CAR ... receptors known as “CARs”. The CAR enables the final product to produce chemicals in ...
(Date:5/31/2019)... , ... May 30, 2019 , ... ... is pleased to announce the strategic acquisition of Metabiologics, Inc., a globally recognized ... provides Object exclusive ownership and commercialization rights to a full spectrum of botulinum ...
Breaking Biology Technology:
Cached News: